ICU Medical Inc.

139.53
-3.12 (-2.19%)
At close: Apr 14, 2025, 1:14 PM
-2.19%
Bid 137.42
Market Cap 3.42B
Revenue (ttm) 2.38B
Net Income (ttm) -117.69M
EPS (ttm) -4.84
PE Ratio (ttm) -28.83
Forward PE 23.82
Analyst Buy
Ask 141.72
Volume 141,177
Avg. Volume (20D) 276,250
Open 144.95
Previous Close 142.65
Day's Range 138.86 - 145.00
52-Week Range 93.36 - 196.26
Beta 0.87

About ICUI

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and SwabTip disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for h...

Sector Healthcare
IPO Date Mar 31, 1992
Employees 15,000
Stock Exchange NASDAQ
Ticker Symbol ICUI
Full Company Profile

Analyst Forecast

According to 4 analyst ratings, the average rating for ICUI stock is "Buy." The 12-month stock price forecast is $200, which is an increase of 43.34% from the latest price.

Stock Forecasts

Next Earnings Release

ICU Medical Inc. is scheduled to release its earnings on May 6, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-2.28%
ICU Medical shares are trading lower. The company ... Unlock content with Pro Subscription
8 months ago
+24.27%
ICU Medical shares are trading higher after the company reported better-than-expected Q2 financial results.